• 227 Citations
  • 8 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ki Hwan Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles
Drug Therapy Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 227 Citations
  • 8 h-Index
  • 34 Article
  • 4 Letter
  • 1 Review article
Bile Ducts
Hepatocellular Carcinoma

A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer

Kim, Y. J., Keam, B., Ock, C. Y., Song, S., Kim, M., Kim, S. H., Kim, K. H., Kim, J. S., Kim, T. M., Kim, D. W., Lee, J. S. & Heo, D. S., 1 Oct 2019, In : Lung Cancer. 136, p. 122-128 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Disease-Free Survival
Health Behavior
Quality of Life

A randomized, Open-Label, phase II study comparing pemetrexed plus cisplatin followed by maintenance pemetrexed versus pemetrexed alone in patients with epidermal growth factor receptor (EGFR)-Mutant non-small cell lung cancer after failure of First-Line EGFR tyrosine kinase inhibitor: KCSG-Lu12-13

Yoo, K. H., Lee, S. J., Cho, J., Lee, K. H., Park, K. U., Kim, K. H., Cho, E. K., Choi, Y. H., Kim, H. R., Kim, H. G., Ahn, H. J., Lee, H. Y., Yun, H. J., Kang, J. H., Jeong, J., Choi, M. Y., Jung, S. H., Sun, J. M., Lee, S. H., Ahn, J. S. & 2 others, Park, K. & Ahn, M. J., 1 Jan 2019, In : Cancer Research and Treatment. 51, 2, p. 718-726 9 p.

Research output: Contribution to journalArticle

Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Open Access
Lymphoma, Large B-Cell, Diffuse
Costs and Cost Analysis